Efficacy and Safety of First-line ART With BIC/FTC/TAF Introduced at the First Clinical Visit

CompletedOBSERVATIONAL

Enrollment

112

Participants

Timeline

Start Date

May 1, 2019

Primary Completion Date

December 31, 2022

Study Completion Date

March 31, 2024

Conditions

HIV Infections

Trial Locations (1)

University Hospital for Infectious Diseases ''Dr. Fran Mihaljevic'', Zagreb

All Listed Sponsors

lead

University Hospital for Infectious Diseases, Croatia

OTHER

NCT06518213 - Efficacy and Safety of First-line ART With BIC/FTC/TAF Introduced at the First Clinical Visit | Biotech Hunter | Biotech Hunter